Sort
48,018 grants matching “immunotherapy”
Moffitt Skin Cancer SPORE
$1,681,718Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2016 · CA
Targeting the DNA damage response in cancer therapy
$1,681,063Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
B-Lymphocyte Immunotherapy in Islet Transplantation
$1,681,007Ali Naji · University Of Pennsylvania · U01 · FY2009 · DK
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
$1,679,941Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · U24 · FY2017 · CA
Mechanisms of Peripheral Induction of T-cell Tolerance
$1,679,927Kristin A. Hogquist · University Of Minnesota · P01 · FY2015 · AI
Mechanisms of Peripheral Induction of T-cell Tolerance
$1,679,927Matthew F Mescher · University Of Minnesota · P01 · FY2013 · AI
Immunotherapy of low grade lymphoid malignancies
$1,679,879Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Seattle Clinical Trials Unit
$1,679,850Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Deciphering CTCF code in mammalian host and viral epigenomes
$1,679,578Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
$1,678,890Fred Hutchinson Cancer Research Center · P01 · FY2001 · CA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,678,538Luis J. Montaner · Wistar Institute · R01 · FY2021 · DA
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,678,283Marina Caskey · Rockefeller University · U01 · FY2019 · AI
Building on the success of the adoptive immunotherapy of cancer
$1,677,370Nicholas P Restifo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
ANCA Glomerulonephritis: From Molecules to Man
$1,677,110Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2019 · DK
Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging population
$1,676,951Eliezer Masliah · National Institute On Aging · ZIA · FY2019 · AG
ANCA Glomerulonephritis: From Molecules to Man
$1,676,555Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2017 · DK
Clinical Trials of Patients with AIDS-Related Malignancies
$1,675,326Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Studies of Inherited Causes of Fungal Susceptability
$1,674,772Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Moffitt Skin Cancer SPORE
$1,672,774Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2013 · CA
Mechanisms Underlying Clearance of Persistent Infections
$1,672,198Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
AIDS CLINICAL TRIALS UNIT
$1,672,194University Of Pennsylvania · U01 · FY2000 · AI
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
$1,672,078Steven W. Dow · Colorado State University · U01 · FY2017 · CA
Immune Regulation in Mycobacterial and Fungal Infections
$1,671,700Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
PASSIVE IMMUNITY TO COCAINE USING NOVEL HUMAN ANTIBODIES
$1,671,351University Of Cincinnati · U19 · FY2001 · DA
eDyNAmiC - STANFORD
$1,670,644Paul S Mischel · Stanford University · OT2 · FY2025 · CA